EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Validation of a New DIVA Real-Time PCR Allowing to Differentiate Wild-Type Lumpy Skin Disease Virus Strains, Including the Asian Recombinant Strains, from Neethling-Based Vaccine Strains

Andy Haegeman iD, Ilse De Leeuw, Wannes Philips, Nick De Regge

Viruses · 2023

DOI: 10.3390/v15040870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Andy Haegeman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sciensano, Infectious Diseases in Animals, Exotic and Vector-Borne Diseases, Groeselenberg 99, B-1180 Brussels, Belgium. Hauptthemen laut MEDLINE: Lumpy skin disease virus, Lumpy Skin Disease, Viral Vaccines, Capripoxvirus. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current epidemic in Asia, driven by LSDV recombinants, poses difficulties to existing DIVA PCR tests, as these do not differentiate between homologous vaccine strains and the recombinant strains. We, therefore, developed and validated a new duplex real-time PCR capable of differentiating Neethling-based vaccine strains from classical and recombinant wild-type strains that are currently circulating in Asia. The DIVA potential of this new assay, seen in the in silico evaluation, was confirmed on samples from LSDV infected and vaccinated animals and on isolates of LSDV recombinants (n = 12), vaccine (n = 5), and classic wild-type strains (n = 6). No cross-reactivity or a-specificity with other capripox viruses was observed under field conditions in non-capripox viral stocks and negative animals. The high analytical sensitivity is translated into a high diagnostic specificity as more than 70 samples were all correctly detected with Ct values very similar to those of a published first-line pan capripox real-time PCR. Finally, the low inter- and intra-run variability observed shows that the new DIVA PCR is very robust which facilitates its implementation in the lab. All validation parameters that are mentioned above indicate the potential of the newly developed test as a promising diagnostic tool which could help to control the current LSDV epidemic in Asia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lumpy skin disease virusLumpy Skin DiseaseViral VaccinesCapripoxvirusAnimalsCattleReal-Time Polymerase Chain ReactionVaccines, Attenuated

Stichwörter der Autor:innen

DIVAlumpy skin diseasereal-time PCRrecombinant strainvaccine strain

Substanzen

Viral VaccinesVaccines, Attenuated

Autor:innen und Institutionen

  • Sciensano, Infectious Diseases in Animals, Exotic and Vector-Borne Diseases, Groeselenberg 99, B-1180 Brussels, Belgium.
  • Sciensano, EURL for Diseases Caused by Capripox Viruses, Groeselenberg 99, B-1180 Brussels, Belgium.

ORCID-Profile: Andy Haegeman

Förderung

  • European Commission

Zitieren

APA

Haegeman, A., De Leeuw, I., Philips, W., & De Regge, N. (2023). Development and Validation of a New DIVA Real-Time PCR Allowing to Differentiate Wild-Type Lumpy Skin Disease Virus Strains, Including the Asian Recombinant Strains, from Neethling-Based Vaccine Strains. Viruses. https://doi.org/10.3390/v15040870

Vancouver

Haegeman A, De Leeuw I, Philips W, De Regge N. Development and Validation of a New DIVA Real-Time PCR Allowing to Differentiate Wild-Type Lumpy Skin Disease Virus Strains, Including the Asian Recombinant Strains, from Neethling-Based Vaccine Strains. Viruses. 2023. doi:10.3390/v15040870

BibTeX
@article{Haegeman2023,
  author = {Haegeman, Andy and De Leeuw, Ilse and Philips, Wannes and De Regge, Nick},
  title = {Development and Validation of a New DIVA Real-Time PCR Allowing to Differentiate Wild-Type Lumpy Skin Disease Virus Strains, Including the Asian Recombinant Strains, from Neethling-Based Vaccine Strains},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15040870}
}
Kostenlos starten →